Medartis Holding AG
MDRSF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | $123 | $113 | $112 | $109 |
| % Growth | 8.6% | 1.6% | 2.5% | – |
| Cost of Goods Sold | $25 | $24 | $22 | $21 |
| Gross Profit | $98 | $89 | $90 | $88 |
| % Margin | 79.5% | 78.7% | 80.3% | 80.8% |
| R&D Expenses | $14 | $21 | $22 | $12 |
| G&A Expenses | $20 | $39 | $0 | $17 |
| SG&A Expenses | $76 | $69 | $72 | $67 |
| Sales & Mktg Exp. | $56 | $102 | $0 | $49 |
| Other Operating Expenses | -$1 | -$13 | $0 | $0 |
| Operating Expenses | $89 | $77 | $94 | $79 |
| Operating Income | $9 | $12 | -$4 | $9 |
| % Margin | 7.5% | 10.7% | -3.8% | 7.9% |
| Other Income/Exp. Net | -$9 | -$12 | $7 | -$6 |
| Pre-Tax Income | $1 | $0 | $2 | $2 |
| Tax Expense | $2 | -$2 | $1 | $0 |
| Net Income | -$1 | $1 | $3 | $1 |
| % Margin | -1.2% | 0.8% | 2.3% | 1.3% |
| EPS | -0.12 | 0.07 | 0.19 | 0.12 |
| % Growth | -271.4% | -63.2% | 58.3% | – |
| EPS Diluted | -0.12 | 0.07 | 0.19 | 0.12 |
| Weighted Avg Shares Out | 12 | 14 | 14 | 12 |
| Weighted Avg Shares Out Dil | 12 | 14 | 14 | 12 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | -$1 | $2 | $0 |
| Interest Expense | $0 | $3 | $2 | $5 |
| Depreciation & Amortization | $12 | $11 | $11 | $11 |
| EBITDA | $20 | $15 | $16 | $18 |
| % Margin | 16.2% | 12.9% | 14% | 16.3% |